Abstract

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?

van der Pluijm RW, Peto TJ, Hamaluba M, Callery JJ, Tripura R, White NJ, Dondorp AM
Lancet Infect Dis. 2022;22

Permenent descriptor
https://doi.org/10.1016/S1473-3099(22)00283-3


No abstract available

Publication metrics
Dimensions Badge

Altmetric

Key Terms
*Artemisinins/therapeutic use | Humans | *Malaria/drug therapy (Source: Medline)
Funded by
Bundesministerium fur Bildung und Forschung (BMBF) [01KI2006D, 01KI20328A, 01KX2021]; Ministry for Science and Culture of Lower Saxony [14-76103-184]; German Research Foundation (DFG) [PO 716/11-1, PO 716/14-1]; Sartorius, Lung research; BMBF [01KI2043, NaFoUniMedCovid19-COVIM 01KX2021]; Bavarian State Ministry for Science and the Arts; DFG [RTG1660, TRR130]; Bayerische Forschungsstiftung; Kastner Foundation; German Center for Infection Research [80018019238]; European Regional Development Fund (Defeat Corona) [ZW7-8515131]
External Sources
Abstract at pubmed
Full text at publishers website
Full text at PMC